Gregory T Lucier
CIK 1251299 · Chairman & CEO · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IVGN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE, NC 28277
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRVI | Director | 311,200 | $7.74 | $2.41M | $773.5K | 12 | 2026-06-10 |
| XRAY | Director | 101,665 | $9.46 | $962.3K | $2.61M | 47 | 2026-06-05 |
| AVTR | Director | 94,006 | $15.89 | $1.49M | $541.2K | 3 | 2026-05-11 |
| Catalent, Inc. (CTLT) Delisted | Director | 0 | $63.48 | $0 | -$2.49M | 18 | 2024-12-18 |
| Bruker Cellular Analysis, Inc. (CELL) Delisted | Director | 0 | $1.00 | $0 | $0 | 2 | 2023-10-03 |
| Bruker Cellular Analysis, Inc. (BLI) Delisted | Director | 477,051 | $1.20 | $572.5K | $1.47M | 9 | 2022-08-01 |
| NUVASIVE INC (NUVA) Delisted | Director | 266,251 | $39.75 | $10.58M | $1.82M | 31 | 2021-05-20 |
| Invuity, Inc. (IVTY) Delisted | Director | 0 | — | — | $594.1K | 12 | 2018-10-23 |
| CAREFUSION Corp (CFN) Delisted | Director | 34,103 | — | — | $0 | 9 | 2014-11-06 |
| LIFE | Chief Executive Officer | 0 | $43.28 | $0 | -$16.85M | 25 | 2014-02-04 |
| Life Technologies Corp (IVGN) Delisted | CEO | 191,910 | — | — | -$40.82M | 25 | 2008-11-18 |
Recent Filings · Page 9 of 20
195 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-22 | XRAY | Grant (A) | +4,766 | $0 | EDGAR |
| 2020-04-14 | XRAY | Grant (A) | +37 | $0 | EDGAR |
| 2020-03-03 | NUVASIVE INC (NUVA) Delisted | Mixed | +19,148 | -$957.3K | EDGAR |
| 2020-02-14 | Catalent, Inc. (CTLT) Delisted | Buy (P) | +2,000 | $119.4K | EDGAR |
| 2020-01-14 | XRAY | Grant (A) | +5 | $0 | EDGAR |
| 2019-11-20 | NUVASIVE INC (NUVA) Delisted | Sell (S) | −29,469 | -$2.15M | EDGAR |
| 2019-10-16 | XRAY | Grant (A) | +6 | $0 | EDGAR |
| 2019-09-11 | Catalent, Inc. (CTLT) Delisted | Mixed | +2,000 | $103.3K | EDGAR |
| 2019-08-26 | Catalent, Inc. (CTLT) Delisted | Grant (A) | +3,167 | $0 | EDGAR |
| 2019-07-16 | XRAY | Grant (A) | +4 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.